Case Report
Published on 07 Jun 2023
Oncolytic virotherapy for metastatic breast cancer – a case report
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1186888
- 2,805 views
- 2 citations
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
805 articles
Original Research
Published on 07 Jun 2023
Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1177133
- 3,702 views
- 6 citations
Editorial
Published on 06 Jun 2023
Editorial: An era of personalized medicine in breast cancer: integrating artificial intelligence into practice
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1164808
- 1,900 views
- 3 citations
Original Research
Published on 05 Jun 2023
Time-related survival prediction in molecular subtypes of breast cancer using time-to-event deep-learning-based models
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1147604
- 5,679 views
- 13 citations
Original Research
Published on 05 Jun 2023
An improved nomogram including elastography for the prediction of non-sentinel lymph node metastasis in breast cancer patients with 1 or 2 sentinel lymph node metastases
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1196592
- 1,833 views
- 2 citations
Original Research
Published on 02 Jun 2023
Diagnostic value of mammography density of breast masses by using deep learning
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1110657
- 2,286 views
- 1 citation
Original Research
Published on 02 Jun 2023
Aberrant expression of bone morphogenetic proteins in the disease progression and metastasis of breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1166955
- 5,616 views
- 12 citations
Original Research
Published on 31 May 2023
C1ql4 regulates breast cancer cell stemness and epithelial-mesenchymal transition through PI3K/AKT/NF-κB signaling pathway
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1192482
- 3,019 views
- 2 citations
Original Research
Published on 29 May 2023
A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1182725
- 3,067 views
- 3 citations
Original Research
Published on 26 May 2023
Medicago Sativa Defensin1 as a tumor sensitizer for improving chemotherapy: translation from anti-fungal agent to a potential anti-cancer agent
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1141755
- 3,422 views
- 8 citations
Original Research
Published on 25 May 2023
Breast cancer survival and the health system in Brazil: an analysis of public and private healthcare
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.927748
- 5,163 views
- 6 citations
Original Research
Published on 25 May 2023
The relationship between women’s body mass index and breast cancer outcomes was U-shaped
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1191093
- 2,237 views
- 3 citations
Original Research
Published on 24 May 2023
DNA methylation differences in noncoding regions in ER negative breast tumors between Black and White women
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1167815
- 2,312 views
- 1 citation
Review
Published on 22 May 2023
Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1131259
- 5,865 views
- 5 citations
Original Research
Published on 19 May 2023
Impact of Atypical Hyperplasia at Surgical Margins on breast cancer outcomes in patients treated with neoadjuvant chemotherapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1202689
- 2,363 views
- 1 citation
Original Research
Published on 19 May 2023
Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma in situ
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1069059
- 7,220 views
- 7 citations